SEC Filings | Zevra Therapeutics, Inc.

Filing date	Form	Description	Filing Group	View
03-30-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-008650.rtf 0001437749-23-008650.xls 0001437749-23-008650.pdf View HTML
03-29-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-008405.rtf 0001437749-23-008405.xls 0001437749-23-008405.pdf View HTML
03-29-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-008416.rtf 0001437749-23-008416.xls 0001437749-23-008416.pdf View HTML
03-29-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-008434.rtf 0001437749-23-008434.xls 0001437749-23-008434.pdf View HTML
03-21-2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0001437749-23-007397.rtf 0001437749-23-007397.xls 0001437749-23-007397.pdf View HTML
03-17-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-006961.rtf 0001437749-23-006961.xls 0001437749-23-006961.pdf View HTML
03-17-2023	DEFC14A	Definitive proxy statement in connection with contested solicitations	Proxy Filings	0001477932-23-001547.rtf 0001477932-23-001547.xls 0001477932-23-001547.pdf View HTML
03-16-2023	PRRN14A	Non-management revised preliminary proxy soliciting materials	Proxy Filings	0001477932-23-001508.rtf 0001477932-23-001508.xls 0001477932-23-001508.pdf View HTML
03-16-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-006905.rtf 0001437749-23-006905.xls 0001437749-23-006905.pdf View HTML
03-15-2023	DEFC14A	Definitive proxy statement in connection with contested solicitations	Proxy Filings	0001437749-23-006586.rtf 0001437749-23-006586.xls 0001437749-23-006586.pdf View HTML

Filing Group

View

03-30-2023